推荐应用
Tumor necrosis factor receptor superfamily, member 17 (TNFRSF17), also known as B cell maturation antigen (BCMA) or CD269 antigen, is a member of the TNF receptor superfamily. It is a type III membrane protein containing one extracellular cysteine rich domain. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. TNFRSF17 can binds to TNFSF13B/BLyS/BAFF and TNFSF13/APRIL, and to lead to NF-kappaB and MAPK8/JNK activation. TNFRSF17 also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation. The identification of TNFRSF17 as a NF-kappaB-activating receptor for TALL-1 suggests molecular targets for drug development against certain immunodeficient or autoimmune diseases. TNFRSF17/BCMA is a target of donor B-cell immunity in patients with myeloma who respond to DLI.
高纯度、高活性、低内毒素、高批间一致性


-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
153
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
155
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
194
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
148
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1955
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1908
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1160
2026-04-22
【应用方向】TNFR蛋白家族概述
1108
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1285
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
956
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
969
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1048
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
878
2026-04-20
【技术讲解】细胞因子科学选型--常见问题解答
11245
2026-09-21
【技术讲解】ADC药物研究相关靶点汇总
19456
2025-07-30





